Entry prices for new medications fall 35%

Comments Off | 01-23-2013

Economic regulation has allowed medications to arrive in the hands of Brazilians at prices 35% lower, on average, than those requested by the pharmaceutical industry. A study released by the National Health Surveillance Agency (ANVISA), on Tuesday, January 15, analyzed the maximum prices established by the Chamber for the Regulation of the Pharmaceutical Market (CMED). 1,115 presentations (pharmaceutical forms such as ointment, syrup, tablet, etc) for 433 medications were approved between March 2004 and December 2011.

According to ANVISA Manager of Economic Evaluation of New Technologies, Gabrielle Troncoso, in most cases the companies request pricing at higher levels than those that end up being authorized by the government. “The study indicated that economic regulation has been effective in reducing the entry prices of medications in our country,” said the manager.

Medications (category I) with innovative chemical formulas that are patented in Brazil and have proven therapeutic gain compared to medication already used for the same indication represented a minority (3.24%) of the products launched by the pharmaceutical industry in Brazil during the period. The majority (45.03%) of products have no patent or proof of therapeutic gain (category II). New combinations of active ingredients already in the country and medications in new pharmaceutical forms amounted to 36.72% of the products analyzed.

In the case of category I medications, the maximum prices established were 19% lower than those requested by the pharmaceutical industry, while category II medications saw a reduction of 37%. Foreign capital companies accounted for almost 82% of all companies that had products classified as category I or II.

In the new combinations of active ingredients already in the country and medications in new presentations (category V) there was a 38% difference between the price fixed and that requested by the industries. For medications classified in the “not included” category and those that could not be classified in any of the categories established by legislation, prices were reduced by 35% and 45% respectively.

Source:

Ministry of Health

  • Facebook
  • LinkedIn
  • MySpace
  • Twitter
  • Yahoo! Buzz
Tags: , , , , , , , , , , ,
Posted in General |

Comments are closed.